Abraham Hartzema

Abraham Hartzema, Pharm.D., MSPH, Ph.D., FISPE

PROFESSOR And EMINENT SCHOLAR EMERITUS

Department: Pharmaceutical Outcomes & Policy
Business Phone: (352) 273-6273
Business Email: hartzema@ufl.edu

About Abraham Hartzema

Abraham G. Hartzema is Professor and Eminent Scholar Emeritus at the University of Florida in the Department of Pharmaceutical Outcomes & Policy. He occupied the Perry A. Foote Chair in Health Outcomes Research, and Professor in Epidemiology and Biostatistics in the College of Public Health and the College of Medicine. In the year 2007, he was awarded the University of Florida Foundation Research award.

Dr. Hartzema has widely published on various aspects of prescription drug safety, including several books on Pharmacoepidemiology. His last book is entitled “Pharmacoepidemiology and Therapeutic Risk Management” was published by Harvey Whitney Book Publishers. Co-edited with Hugh Tilson (UNC-Chapel Hill) and Arnold Chan (Harvard University) the book reflects the new therapeutic risk management paradigm as implemented by the US FDA.

He has served on the scientific board of the FIP from 1988-1996; and on editorial boards, including Medical Care, Annals of Pharmacotherapy, Clinical Therapeutics, the International Journal of Pharmacy Practice, Pulmonary Circulation and others. In 2003 he was bestowed fellow status in the International Society on Pharmacoepidemiology. He has been the Chair of Data Safety and Monitoring Boards. He has also served on the University of Florida Graduate Council, and grant review panels for AHRQ, FDA, HealthCanada, DSEN, NASA, NIH, and NIHBL. He currently serves on the United States Pharmacopeia: Nomenclature, Safety and Labeling Expert Committee. He was recently appointed as Senior Advisor to the FDA, Center for Devices and Radiological Health.

Dr. Hartzema’s research funded by the Agency for Healthcare Research and Quality, NIH, the FDA, the Florida Office of Rural Health and several pharmaceutical companies. His recent study (2020-2022) on preventing opioid misuse is funded by the NIH/NIDA. Theoretical interests are in data mining techniques, developing metrics for the benefit/risk ratio of drugs, methods development for active medical product safety surveillance, and bias calibration in observational methods.

Dr. Hartzema was on faculty leave (2008–2009) in the US Food and Drug Administration’s Immediate Office of the Commissioner working on the Congressional mandated Sentinel Initiative. He also served as a Principle Investigator on the Observational Medical Outcomes Partnership (OMOP), a public-private partnership between the US-FDA, the Foundation of the National Institute of Health and PhRMA. He is currently a participant in the research group Observational Health Data Sciences and Informatics (OHDSI) research program.

Research Profile

Health outcomes research with an emphasis on: Pharmacoepidemiology, Active Drug Safety, Surveillance methods development, Therapeutic risk management and Program evaluation

Publications

2020
Challenges facing drug utilization research in the Latin American region.
Pharmacoepidemiology and drug safety. 29(11):1353-1363 [DOI] 10.1002/pds.4989. [PMID] 32419226.
2020
Metabolic syndrome and metabolically healthy status in adults with overweight or obesity, expressing no desire to lose weight.
Obesity research & clinical practice. 14(1):47-53 [DOI] 10.1016/j.orcp.2019.11.007. [PMID] 31883739.
2020
Increased Risk of Acute Pancreatitis with Codeine Use in Patients with a History of Cholecystectomy.
Digestive diseases and sciences. 65(1):292-300 [DOI] 10.1007/s10620-019-05803-3. [PMID] 31468265.
2019
Prevalence of Maternal-Risk Factors Related to Neonatal Abstinence Syndrome in a Commercial Claims Database: 2011-2015.
Pharmacotherapy. 39(10):1005-1011 [DOI] 10.1002/phar.2315. [PMID] 31361913.
2019
Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive Therapy.
Inflammatory bowel diseases. 25(8):1417-1427 [DOI] 10.1093/ibd/izz001. [PMID] 30839057.
2019
Decline in dopamine agonists prescribing and characteristics of drugs prescribed during ambulatory office visits for restless legs syndrome: the National Ambulatory Medical Care Survey 2007-2015.
Sleep medicine. 54:238-243 [DOI] 10.1016/j.sleep.2018.11.011. [PMID] 30590306.
2018
Adherence and persistence to ropinirole, pramipexole, and gabapentin in patients with newly diagnosed restless legs syndrome.
Sleep medicine. 44:45-52 [DOI] 10.1016/j.sleep.2017.11.1139. [PMID] 29530369.
2018
Association Between Recombinant Human Bone Morphogenetic Proteins and Postoperative Opioid Use in Lumbar Fusion Procedure Patients: A Propensity Score-Matched Analysis.
World neurosurgery. 120:e42-e52 [DOI] 10.1016/j.wneu.2018.07.125. [PMID] 30170146.
2018
Comparative risk of lipophilic and hydrophilic statins on incident depression: A retrospective cohort study.
Journal of affective disorders. 238:542-546 [DOI] 10.1016/j.jad.2018.06.021. [PMID] 29936394.
2017
Prices of Generic Drugs Associated with Numbers of Manufacturers.
The New England journal of medicine. 377(26):2597-2598 [DOI] 10.1056/NEJMc1711899. [PMID] 29281576.
2017
High Generic Drug Prices and Market Competition: A Retrospective Cohort Study.
Annals of internal medicine. 167(3):145-151 [DOI] 10.7326/M16-1432. [PMID] 28672324.
2017
Trends in utilization of warfarin and direct oral anticoagulants in older adult patients with atrial fibrillation.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 74(16):1237-1244 [DOI] 10.2146/ajhp160756. [PMID] 28652320.
2017
Comments on prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract.
American journal of obstetrics and gynecology. 216(2):197-198 [DOI] 10.1016/j.ajog.2016.09.099. [PMID] 27687215.
2017
Combining adverse pregnancy and perinatal outcomes for women exposed to antiepileptic drugs during pregnancy, using a latent trait model.
BMC pregnancy and childbirth. 17(1) [DOI] 10.1186/s12884-016-1190-7. [PMID] 28061833.
2017
Duration of Reproductive Years and the Risk of Cardiovascular and Cerebrovascular Events in Older Women: Insights from the National Health and Nutrition Examination Survey.
Journal of women's health (2002). 26(10):1047-1052 [DOI] 10.1089/jwh.2016.6013. [PMID] 28525295.
2016
Comparison of Utilization and Clinical Outcomes for Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 16(11):3202-3211 [DOI] 10.1111/ajt.13853. [PMID] 27137884.
2016
Stimulant use following the publicity of cardiovascular safety and the introduction of patient medication guides.
Pharmacoepidemiology and drug safety. 25(6):678-86 [DOI] 10.1002/pds.3894. [PMID] 26597624.
2015
A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance.
Drug safety. 38(8):749-65 [DOI] 10.1007/s40264-015-0297-5. [PMID] 26055920.
2015
Antiepileptic drug use by pregnant women enrolled in Florida Medicaid.
Neurology. 84(9):944-50 [DOI] 10.1212/WNL.0000000000001304. [PMID] 25653296.
2015
Application of multicategory exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research Datalink.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 18(2):260-70 [DOI] 10.1016/j.jval.2014.11.007. [PMID] 25773561.
2015
Erratum to: A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance.
Drug safety. 38(8):767-8 [DOI] 10.1007/s40264-015-0322-8. [PMID] 26136091.
2014
Hospital Volume and Outcomes for Total Hip Arthroplasty
Pharmacoepidemiology and Drug Safety. 23(1, SI):488-489
2014
Statistical Approaches for Competing Risk in Kidney Transplant (Kt) Outcome Research.
American Journal of Transplantation. 14(3)
2014
Is fidaxomicin worth the cost? The verdict is still out!
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 58(4):604-5 [DOI] 10.1093/cid/cit774. [PMID] 24300046.
2014
Health Outcomes and Medical Effectiveness Research (Homer): a Systematic Approach To Exploring Hill’s Causal Viewpoints in Observational Data
Pharmacoepidemiology and Drug Safety. 23(1, SI):145-146
2014
Use of Optional Icd-9-Cm Articulating Surface Codes for Total Hip Arthroplasty in Us Claims Data
Pharmacoepidemiology and Drug Safety. 23(1, SI)
2014
Combining Adverse Perinatal and Pregnancy Outcomes Using a Latent Trait Model
Pharmacoepidemiology and Drug Safety. 23(1, SI)
2014
Comparison of Rates of Prescribing Oral Corticosteroids for Asthma Exacerbations Between Step-Down Therapy Approaches Among Initiators of Inhaled Corticosteroids and Long-Acting Beta-Agonist Combination Therapy
. 133(2, S)
2014
A Systematic Statistical Approach To Evaluating Evidence From Observational Studies
Journal of education and health promotion. 1:11-39 [DOI] 10.1146/annurev-statistics-022513-115645. [PMID] 24741664.
2014
Pediatric exclusivity: evolving legislation and novel complexities within pediatric therapeutic development.
The Annals of pharmacotherapy. 48(3):369-79 [DOI] 10.1177/1060028013514031. [PMID] 24311725.
2014
Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest.
Drug safety. 37(8):557-67 [DOI] 10.1007/s40264-014-0189-0. [PMID] 24985530.
2013
A comparison of the empirical performance of methods for a risk identification system.
Drug safety. 36 Suppl 1:S143-58 [DOI] 10.1007/s40264-013-0108-9. [PMID] 24166231.
2013
Variation in choice of study design: findings from the Epidemiology Design Decision Inventory and Evaluation (EDDIE) survey.
Drug safety. 36 Suppl 1:S15-25 [DOI] 10.1007/s40264-013-0103-1. [PMID] 24166220.
2013
Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology.
BMJ (Clinical research ed.). 347 [DOI] 10.1136/bmj.f6320. [PMID] 24192967.
2013
Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 185(2):E115-20 [DOI] 10.1503/cmaj.120677. [PMID] 23209115.
2013
Response to comment on ’empirical assessment of methods for risk identification in healthcare data’.
Statistics in medicine. 32(6):1075-7 [DOI] 10.1002/sim.5725. [PMID] 23413215.
2013
Polycystic ovary syndrome and combined oral contraceptive use: a comparison of clinical practice in the United States to treatment guidelines.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 29(4):365-9 [DOI] 10.3109/09513590.2012.743007. [PMID] 23311996.
2013
Managing data quality for a drug safety surveillance system.
Drug safety. 36 Suppl 1:S49-58 [DOI] 10.1007/s40264-013-0098-7. [PMID] 24166223.
2013
Risk of acute kidney injury associated with the use of fluoroquinolones.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 185(10):E475-82 [DOI] 10.1503/cmaj.121730. [PMID] 23734036.
2013
Long-Acting Beta-Agonists and Asthma Exacerbations Requiring Short Courses of Oral Corticosteroids: a Multi-Category Exposure Marginal Structural Models Analysis
Value in Health. 16
2013
Male breast cancer and 5α-reductase inhibitors finasteride and dutasteride.
The Journal of urology. 190(5):1811-4 [DOI] 10.1016/j.juro.2013.04.132. [PMID] 23665270.
2013
Defining a reference set to support methodological research in drug safety.
Drug safety. 36 Suppl 1:S33-47 [DOI] 10.1007/s40264-013-0097-8. [PMID] 24166222.
2013
Drospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol?
Journal of thrombosis and haemostasis : JTH. 11(6):1059-68 [DOI] 10.1111/jth.12224. [PMID] 23574590.
2013
Drospirenone and Risk for Venous Thromboembolism; a Comparison By Dosage of Ethinyl-Estradiol
Pharmacoepidemiology and Drug Safety. 22(1, SI):261-262
2013
Prescribing Long-Acting Beta-Agonists as Monotherapy To Adults With Controlled and Uncontrolled Asthma
Value in Health. 16
2013
Fluoroquinolones and Risk for Acute Kidney Injury
Pharmacoepidemiology and Drug Safety. 22(1, SI)
2013
Evaluating the impact of database heterogeneity on observational study results.
American journal of epidemiology. 178(4):645-51 [DOI] 10.1093/aje/kwt010. [PMID] 23648805.
2012
Assessing the association between omalizumab and arteriothrombotic events through spontaneous adverse event reporting.
Journal of asthma and allergy. 5:1-9 [DOI] 10.2147/JAA.S29811. [PMID] 22690127.
2012
Transfusion practices in the management of sickle cell disease: a survey of Florida hematologists/oncologists.
ISRN hematology. 2012 [DOI] 10.5402/2012/524513. [PMID] 23316379.
2012
Utilization of Antiepileptic Drugs in Florida Medicaid Women With Epilepsy of Childbearing Age
Pharmacoepidemiology and Drug Safety. 21
2012
Validation of a common data model for active safety surveillance research.
Journal of the American Medical Informatics Association : JAMIA. 19(1):54-60 [DOI] 10.1136/amiajnl-2011-000376. [PMID] 22037893.
2012
Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership.
Statistics in medicine. 31(30):4401-15 [DOI] 10.1002/sim.5620. [PMID] 23015364.
2011
Methods Development in Active Drug Safety Surveillance Highlighting the Observational Medical Outcomes Partnership’s Findings
Pharmacoepidemiology and Drug Safety. 20
2011
Health Related Quality of Life as Confounder in Observational Studies for Localized Prostate Cancer
Pharmacoepidemiology and Drug Safety. 20
2011
Hydroxyurea use in patients with sickle cell disease in a Medicaid population.
American journal of hematology. 86(10):888-90 [DOI] 10.1002/ajh.22134. [PMID] 21922530.
2011
Inhaled and Intranasal Corticosteroids and Behavioral and Psychiatric Problems: a Pharmacovigilance Analysis Using Aers Data
Pharmacoepidemiology and Drug Safety. 20
2011
Utilizing Medicare claims data for real‐time drug safety evaluations:is it feasible?
Pharmacoepidemiology and drug safety. 20(7):684-8 [PMID] 21847800.
View on: PubMed
2010
Is antiepileptic drug use related to depression and suicidal ideation among patients with epilepsy?
Epilepsy & behavior : E&B. 19(3):494-500 [DOI] 10.1016/j.yebeh.2010.08.030. [PMID] 20880757.
2010
Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership.
Annals of internal medicine. 153(9):600-6 [DOI] 10.7326/0003-4819-153-9-201011020-00010. [PMID] 21041580.
2009
Development and evaluation of a patient empowerment video to promote hydroxyurea adoption in sickle cell disease.
Journal of the National Medical Association. 101(3):251-7 [PMID] 19331257.
View on: PubMed
2009
Is Antiepileptic Drug Use Associated With Suicidality in Patients With Epilepsy?
Epilepsia. 50
2009
Lives in isolation: stories and struggles of low-income African American women with panic disorder.
CNS neuroscience & therapeutics. 15(3):210-9 [DOI] 10.1111/j.1755-5949.2009.00079.x. [PMID] 19691540.
2009
The cost of health care for children and adults with sickle cell disease.
American journal of hematology. 84(6):323-7 [DOI] 10.1002/ajh.21408. [PMID] 19358302.
2009
Detection of Progressive Multifocal Leukoencephalopathy Reports Associated With Natalizumab Pre- and Post-Risk Minimization Action Plan From Adverse Event Reporting System Database
Value in Health. 12 [DOI] 10.1016/S1098-3015(10)74048-1.
2008
Cost-utility analysis of rimonabant in the treatment of obesity.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 11(3):389-99 [DOI] 10.1111/j.1524-4733.2007.00281.x. [PMID] 18179661.
2008
Effect of an academic detailing intervention on the utilization rate of cyclooxygenase-2 inhibitors in the elderly.
The Annals of pharmacotherapy. 42(6):749-56 [DOI] 10.1345/aph.1K537. [PMID] 18430793.
2008
Risk drinking behavior among psychotropic drug users in an aging Finnish population: the FinDrink study.
Alcohol (Fayetteville, N.Y.). 42(4):261-7 [DOI] 10.1016/j.alcohol.2008.02.002. [PMID] 18400450.
2008
Risk Drinking Behaviour Among Psychotropic Drug Users in An Aging Finnish Population: the Findrink Study
Pharmacoepidemiology and Drug Safety. 17:S96-S97
2008
Risk of Tendon Rupture After Quinolone Use in a Us Military Population
Pharmacoepidemiology and Drug Safety. 17
2007
Planning for pharmacy health information technology in critical access hospitals.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 64(3):315-21 [PMID] 17244881.
View on: PubMed
2007
The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer.
The breast journal. 13(6):581-7 [PMID] 17983400.
View on: PubMed
2007
Ethnic differences in the reliability and validity of a Panic Disorder Screen.
Ethnicity & health. 12(3):283-96 [PMID] 17454101.
View on: PubMed
2006
Discordance between availability of pharmacogenetics studies and pharmacogenetics-based prescribing information for the top 200 drugs.
The Annals of pharmacotherapy. 40(4):639-44 [PMID] 16595569.
View on: PubMed
2006
Effectiveness of nesiritide on dialysis or all-cause mortality in patients undergoing cardiothoracic surgery.
Clinical cardiology. 29(1):18-24 [PMID] 16477773.
View on: PubMed
2006
Medication safety infrastructure in critical-access hospitals in Florida.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 63(5):442-50 [PMID] 16484518.
View on: PubMed
2006
Pharmacoeconomic modeling of nesiritide versus dobutamine for decompensated heart failure.
Pharmacotherapy. 26(1):34-43 [PMID] 16509026.
View on: PubMed
2006
The effects of prophylactic iron given in prenatal supplements on iron status and birth outcomes: a randomized controlled trial.
American journal of obstetrics and gynecology. 194(2):512-9 [PMID] 16458655.
View on: PubMed
2006
The roles of teaching hospitals, insurance status, and race/ethnicity in receipt of adjuvant therapy for regional-stage breast cancer in Florida.
American journal of public health. 96(1):160-6 [PMID] 16317209.
View on: PubMed
2006
Correction for errors in measuring adherence to prenatal multivitamin/mineral supplement use among low-income women.
The Journal of nutrition. 136(2):479-83 [PMID] 16424131.
View on: PubMed
2005
Pharmacy-specific quality indicators for asthma therapy.
Research in social & administrative pharmacy : RSAP. 1(3):430-45 [PMID] 17138488.
View on: PubMed
2005
Pill count adherence to prenatal multivitamin/mineral supplement use among low-income women.
The Journal of nutrition. 135(5):1093-101 [PMID] 15867287.
View on: PubMed
2004
Availability of pharmacogenomics-based prescribing information in drug package inserts for currently approved drugs.
The pharmacogenomics journal. 4(6):354-8 [PMID] 15483659.
View on: PubMed
2004
Disability measures in stroke: relationship among the Barthel Index, the Functional Independence Measure, and the Modified Rankin Scale.
Stroke. 35(4):918-23 [PMID] 14976324.
View on: PubMed
2004
Intranasal vaccine for prevention of influenza in children.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 61(16):1716-20 [PMID] 15540486.
View on: PubMed
2003
Levalbuterol is not more cost-effective than albuterol for COPD.
Chest. 124(3):1176; author reply 1176-8 [PMID] 12970057.
View on: PubMed
2003
Labor costs associated with incontinence in long-term care facilities.
Urology. 62(3):442-6 [PMID] 12946743.
View on: PubMed
2002
Attitudinal factors among adult prescription recipients associated with choice of where to be vaccinated.
Journal of clinical epidemiology. 55(3):279-84 [PMID] 11864799.
View on: PubMed
2002
Patients’ views of priority setting for new medicines. A qualitative study of patients with rheumatoid arthritis.
Scandinavian journal of rheumatology. 31(6):324-9 [PMID] 12492246.
View on: PubMed
2001
Asthma self-management: the perspective of children.
Patient education and counseling. 45(3):199-209 [PMID] 11722856.
View on: PubMed
2001
Effect of vaccination by community pharmacists among adult prescription recipients.
Medical care. 39(4):340-8 [PMID] 11329521.
View on: PubMed
2001
People vaccinated by pharmacists: descriptive epidemiology.
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996). 41(1):46-52 [PMID] 11216111.
View on: PubMed
1999
Economic assessment of three antimicrobial therapies for uncomplicated urinary tract infection in women.
Clinical therapeutics. 21(9):1578-88 [PMID] 10509852.
View on: PubMed
1999
Physician over-the-counter drug prescribing patterns: an analysis of the National Ambulatory Medical Care Survey.
The Annals of pharmacotherapy. 33(4):400-5 [PMID] 10332528.
View on: PubMed
1997
Demographics, health behaviors, and past drug use as predictors of recall accuracy for previous prescription medication use.
Journal of clinical epidemiology. 50(8):975-80 [PMID] 9291884.
View on: PubMed
1995
Recall accuracy for prescription medications: self-report compared with database information.
American journal of epidemiology. 142(10):1103-12 [PMID] 7485055.
View on: PubMed
1995
Self-initiated modification of hypertension treatment in response to perceived problems.
The Annals of pharmacotherapy. 29(12):1213-17 [PMID] 8672823.
View on: PubMed
1993
Computerized monitoring protocols as a pharmaceutical care practice enhancement: a conceptual illustration using diabetes mellitus.
The Annals of pharmacotherapy. 27(7-8):963-6 [PMID] 8364283.
View on: PubMed
1993
Left-sided leg edema of the elderly: a common variant of the iliac compression syndrome.
The Journal of the American Board of Family Practice. 6(1):1-4 [PMID] 8421924.
View on: PubMed
1993
Pharmacoepidemiology of bleeding events after use of r-alteplase or streptokinase in acute myocardial infarction.
The Annals of pharmacotherapy. 27(7-8):956-62 [PMID] 8364282.
View on: PubMed
1992
Pharmacoepidemiology–its relevance to clinical practice.
Journal of clinical pharmacy and therapeutics. 17(2):73-4 [PMID] 1583081.
View on: PubMed
1992
Pharmacoepidemiology and military medical automation: opportunity for excellence.
Military medicine. 157(6):302-7 [PMID] 1620399.
View on: PubMed
1992
Community pharmacists as immunization advocates. Cost-effectiveness of a cue to influenza vaccination.
Medical care. 30(6):503-13 [PMID] 1593916.
View on: PubMed
1992
Guide to interpreting and evaluating the pharmacoepidemiologic literature.
The Annals of pharmacotherapy. 26(1):96-8 [PMID] 1535003.
View on: PubMed
1991
Pharmaceutical sciences’ manpower supply and internal rate of return.
Pharmaceutical research. 8(6):676-82 [PMID] 2062796.
View on: PubMed
1988
Clinical education for hospital pharmacists in The Netherlands and the United States of America: some observations.
Pharmaceutisch weekblad. Scientific edition. 10(4):158-69 [PMID] 3174368.
View on: PubMed
1987
Drug utilization study methodologies: national and international perspectives.
Drug intelligence & clinical pharmacy. 21(12):994-1001 [PMID] 3428169.
View on: PubMed
1987
Evolving health care systems: academic implications for content and skill.
American journal of pharmaceutical education. 51(4):399-401 [PMID] 10286994.
View on: PubMed
1987
Implementation of a total parenteral nutrition program in the skilled nursing facility: role of the nursing director.
Nursing homes and senior citizen care. 36(5):24-6 [PMID] 10312203.
View on: PubMed
1987
Introduction to pharmacoepidemiology.
Drug intelligence & clinical pharmacy. 21(9):739-40 [PMID] 3652936.
View on: PubMed
1987
The contribution of epidemiology to the study of drugs.
Drug intelligence & clinical pharmacy. 21(9):741-7 [PMID] 3308393.
View on: PubMed
1983
Nonmedical factors associated with the prescribing volume among family practitioners in an HMO.
Medical care. 21(10):990-1000 [PMID] 6656329.
View on: PubMed
1982
Personality traits and theophylline metabolism.
Biopharmaceutics & drug disposition. 3(4):311-6 [PMID] 7159687.
View on: PubMed
1981
Documenting outpatient problem intervention activities of pharmacists in an HMO.
Medical care. 19(1):104-17 [PMID] 7464303.
View on: PubMed

Teaching Profile

Courses Taught
2009-2018
PHA7979 Advanced Research
2010-2015,2017-2018
PHA7980 Research for Doctoral Dissertation
2010-2017
PHA6937 Topics in Pharmaceutical Administration
2017
PHA6717 Measurement in Pharmacy Administration Research
2010-2012,2014-2016
PHA6935 Selected Topics in Pharmacy
2010-2016
PHA6910 Supervised Research
2010-2016
PHA6936 Advanced Topics in Pharmaceutical Sciences
2006-2008,2010-2015,2013-2016
PHA6268 Pharmacoepidemiology and Patient Safety
2015
PHA6265 Introduction to Pharmaceutical Outcomes and Policy I
2010-2015
PHA6279 Pharmaceutical Outcomes and Policy Seminar
2006,2008-2010,2010-2014,2013-2015
PHA6266 Introduction to Pharmaceutical Outcomes and Policy II
2013-2014
PHA6805 Applied Data Interpretation and Reporting of Findings in Pharmacy
2014
PHA6938 Research Seminar
2013
PHA5267 Crit Appr Pharmacoeco
2010-2012
PHA6971 Masters Research
2011
PHA6940 Supervised Teaching
2010
PHA5901 Res Ph Outcome and Plcy

Contact Details

Phones:
Business:
(352) 273-6273
Emails:
Business:
hartzema@ufl.edu

recent news

Gators recognized at the 35th International Conference on Pharmacoepidemiology in Philadelphia

Dr. Hartzema appointed advisor at Chinese health economics research institute

Hartzema to serve as advisor at Institute for Health Economics Research Institute at Sun Yat-Sen University School of Pharmaceutical Sciences.